Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex
- PMID: 15199066
- DOI: 10.1074/jbc.M400521200
Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex
Abstract
Noggin and sclerostin are bone morphogenetic protein (BMP) antagonists that modulate mitogenic activity through sequestering BMPs. Little is known of the interactions among this class of proteins. We show that recombinant sclerostin and noggin bound to each other with high affinity (K(D) = 2.92 nm). This observation has been extended to naturally expressed noggin and sclerostin from the rat osteosarcoma cell line, ROS 17/2.8, supporting a role for the complex in natural systems. The noggin-sclerostin complex was competitive with BMP binding and mutually attenuated the activity of each BMP antagonist. Collectively, the data demonstrate a novel and exquisite paradigm for the regulation of BMP activity through direct neutralization of the BMP and activation by co-localized BMP antagonist expression. The pleiotrophic nature of noggin and sclerostin represents a novel mechanism for the fine-tuning of BMP activity in bone homeostasis.
Similar articles
-
Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins.J Biol Chem. 2005 Jan 28;280(4):2498-502. doi: 10.1074/jbc.M400524200. Epub 2004 Nov 12. J Biol Chem. 2005. PMID: 15545262
-
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.J Exp Med. 2004 Mar 15;199(6):805-14. doi: 10.1084/jem.20031454. J Exp Med. 2004. PMID: 15024046 Free PMC article.
-
Bone morphogenetic protein-2 and -4 limit the number of enteric neurons but promote development of a TrkC-expressing neurotrophin-3-dependent subset.J Neurosci. 2004 Apr 28;24(17):4266-82. doi: 10.1523/JNEUROSCI.3688-03.2004. J Neurosci. 2004. PMID: 15115823 Free PMC article.
-
Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN.Arthritis Res. 2001;3(1):1-5. doi: 10.1186/ar133. Epub 2000 Nov 14. Arthritis Res. 2001. PMID: 11178121 Free PMC article. Review.
-
Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism.Expert Opin Ther Targets. 2009 Jan;13(1):123-37. doi: 10.1517/14728220802637725. Expert Opin Ther Targets. 2009. PMID: 19063711 Review.
Cited by
-
Bone morphogenetic proteins and their antagonists.Rev Endocr Metab Disord. 2006 Jun;7(1-2):51-65. doi: 10.1007/s11154-006-9000-6. Rev Endocr Metab Disord. 2006. PMID: 17029022 Review.
-
Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays.J Clin Endocrinol Metab. 2011 Jul;96(7):E1159-62. doi: 10.1210/jc.2011-0254. Epub 2011 May 4. J Clin Endocrinol Metab. 2011. PMID: 21543425 Free PMC article.
-
Paracrine interaction between adipose-derived stromal cells and cranial suture-derived mesenchymal cells.Plast Reconstr Surg. 2010 Sep;126(3):806-821. doi: 10.1097/PRS.0b013e3181e5f81a. Plast Reconstr Surg. 2010. PMID: 20811214 Free PMC article.
-
The DAN family: modulators of TGF-β signaling and beyond.Protein Sci. 2014 Aug;23(8):999-1012. doi: 10.1002/pro.2485. Epub 2014 Jun 2. Protein Sci. 2014. PMID: 24810382 Free PMC article. Review.
-
Sclerostin-erbB-3 interactions: modulation of erbB-3 activity by sclerostin.Biochem Biophys Res Commun. 2010 Nov 12;402(2):421-4. doi: 10.1016/j.bbrc.2010.10.048. Epub 2010 Oct 14. Biochem Biophys Res Commun. 2010. PMID: 20951118 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases